Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes.
In this paper we report that intraperitoneal administration of type II collagen in a soluble form protects DBA/1 mice against collagen-induced arthritis (CIA) on subsequent arthritogenic challenge with soluble type II collagen in adjuvant. The degree of arthritis suppression, which is expressed in t...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1989
|
| _version_ | 1826279280908173312 |
|---|---|
| author | Williams, R Whyte, A Waldmann, H |
| author_facet | Williams, R Whyte, A Waldmann, H |
| author_sort | Williams, R |
| collection | OXFORD |
| description | In this paper we report that intraperitoneal administration of type II collagen in a soluble form protects DBA/1 mice against collagen-induced arthritis (CIA) on subsequent arthritogenic challenge with soluble type II collagen in adjuvant. The degree of arthritis suppression, which is expressed in terms of reduced incidence of arthritis, delayed onset and reduced anti-collagen antibody titres, depends on the dose and timing of the pre-immunization collagen injection. In order to elucidate the rôles of CD4+ and CD8+ T lymphocytes subsets in arthritis resistance we administered monoclonal antibodies (mAb) to these antigenic determinants around the time of immunization with soluble type II collagen. Anti-CD4 mAb caused abrogation of arthritis resistance while anti-CD8 mAb was less effective. However, administration of anti-CD8 mAb two weeks after pre-immunization with soluble collagen was very effective in reversing arthritis resistance. From these findings we conclude that CD4+ and CD8+ T cells are involved in resistance to arthritis though the relative importance of each subset changes during the course of the process leading to resistance to CIA. |
| first_indexed | 2024-03-06T23:56:23Z |
| format | Journal article |
| id | oxford-uuid:745b64d4-7de9-4f6b-b485-28e3f5c5275a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T23:56:23Z |
| publishDate | 1989 |
| record_format | dspace |
| spelling | oxford-uuid:745b64d4-7de9-4f6b-b485-28e3f5c5275a2022-03-26T20:02:15ZResistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:745b64d4-7de9-4f6b-b485-28e3f5c5275aEnglishSymplectic Elements at Oxford1989Williams, RWhyte, AWaldmann, HIn this paper we report that intraperitoneal administration of type II collagen in a soluble form protects DBA/1 mice against collagen-induced arthritis (CIA) on subsequent arthritogenic challenge with soluble type II collagen in adjuvant. The degree of arthritis suppression, which is expressed in terms of reduced incidence of arthritis, delayed onset and reduced anti-collagen antibody titres, depends on the dose and timing of the pre-immunization collagen injection. In order to elucidate the rôles of CD4+ and CD8+ T lymphocytes subsets in arthritis resistance we administered monoclonal antibodies (mAb) to these antigenic determinants around the time of immunization with soluble type II collagen. Anti-CD4 mAb caused abrogation of arthritis resistance while anti-CD8 mAb was less effective. However, administration of anti-CD8 mAb two weeks after pre-immunization with soluble collagen was very effective in reversing arthritis resistance. From these findings we conclude that CD4+ and CD8+ T cells are involved in resistance to arthritis though the relative importance of each subset changes during the course of the process leading to resistance to CIA. |
| spellingShingle | Williams, R Whyte, A Waldmann, H Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. |
| title | Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. |
| title_full | Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. |
| title_fullStr | Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. |
| title_full_unstemmed | Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. |
| title_short | Resistance to collagen-induced arthritis in DBA/1 mice by intraperitoneal administration of soluble type II collagen involves both CD4+ and CD8+ T lymphocytes. |
| title_sort | resistance to collagen induced arthritis in dba 1 mice by intraperitoneal administration of soluble type ii collagen involves both cd4 and cd8 t lymphocytes |
| work_keys_str_mv | AT williamsr resistancetocollageninducedarthritisindba1micebyintraperitonealadministrationofsolubletypeiicollageninvolvesbothcd4andcd8tlymphocytes AT whytea resistancetocollageninducedarthritisindba1micebyintraperitonealadministrationofsolubletypeiicollageninvolvesbothcd4andcd8tlymphocytes AT waldmannh resistancetocollageninducedarthritisindba1micebyintraperitonealadministrationofsolubletypeiicollageninvolvesbothcd4andcd8tlymphocytes |